WVE - Wave Pharma Company Long-Term Debts

Public company logo of Wave Life Sciences Corp (WVE)

Wave Life Sciences (WVE) develops innovative RNA therapeutics for the treatment of hereditary pathologies, utilizing unique stereopurity technology to capture a share of the precision medicine market. Financial stability for Wave Life Sciences (WVE) is ensured by tranches from pharma behemoths, rendering the company independent of external factors. The share price history, where the indicator stands at 0.04, confirms the resilience of a business protected by stringent patent barriers and strict regulatory oversight.

WVE (Wave Life Sciences Corp) Company Long-Term Debts history from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for Wave Life Sciences Corp (WVE)

- current quotes and average value forecast:
Stock Quotes wavelifesciences.com|WVE - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Wave Life Sciences|WVE - Real Price to Acquire Entire Company
- book value of equity indicators:
Net Assets per Single Share Wave Life Sciences|WVE - Book Capitalization|Market-to-Book Ratio wavelifesciences.com|WVE - Cumulative Company Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Wave Life Sciences|WVE - Long-Term Debt to Equity|Short-Term Debt to Equity Wave Pharma|WVE - Company Aggregate Debts|Debts to Net Assets Wave Life Sciences|WVE - Company Long-Term Debts|Current Liabilities Wave Life Sciences|Immediate Liquidity wavelifesciences.com
Summary company analytics:WVE wavelifesciences.com
Brand item of Wave Pharma

This indicator aggregates all liabilities with a maturity of over one year, reflecting the capital structure's dependence on external financing and the cost of servicing borrowed resources. For Wave Life Sciences (WVE), whose RNA research expenditures exceed current revenues, the trend of the issuer's long-term liabilities serves as a key marker of balance sheet stability in the absence of regular sales revenue.

Who Wave Life Sciences competes with

TEM - Company Long-Term Liabilities|Qiagen - Company Long-Term Debts|IONS - Company Long-Term Debts|RGEN (Repligen Corp.) - Company Long-Term Liabilities|RNA (Avidity Corp) - Company Long-Term Debt|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|Long-Term Debt genedx.com WGS|Company Long-Term Liabilities RARE (Ultragenyx)|BEAM (Beam Therapeutics Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|Twist Bioscience Corp - Company Long-Term Debt|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt Volume intelliatx.com NTLA|STOK: Company Long-Term Debts|Long-Term Liabilities BLFS (BioLife Solutions Inc)|MAZE (Maze Tx) - Company Long-Term Debts|Long-Term Debt Sionna Corp SION|Company Long-Term Liabilities PRME (Prime Medicine, Inc.)|TSHA (tayshagtx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt uniQure QURE|Long-Term Debt Volume MeiraGTx Holdings (MGTX)|Regenxbio - Company Long-Term Debts|Solid Corp (SLDB) - Company Long-Term Liabilities|OCGN: Company Long-Term Debts|PACB - Long-Term Debt Volume|BNTC (Benitec Biopharma) - Company Long-Term Debts|Long-Term Debt Design Therapeutics Inc DSGN|Company Long-Term Debt Rocket Pharmaceuticals Inc (RCKT)|4D Molecular Corp - Company Long-Term Indebtedness|Company Long-Term Debts LXEO (Lexeo Therapeutics, Inc.)|KRRO - Company Long-Term Liabilities|Editas Medicine - Company Long-Term Debts|Long-Term Debt Silence Therapeutics PLC|proqr.com (PRQR) - Company Long-Term Debt|CDXS - Long-Term Debt Volume|Company Long-Term Liabilities SGMO|Company Long-Term Liabilities Nautilus Biotechnology Inc (NAUT)|Company Long-Term Liabilities MGX (Metagenomi)|Company Long-Term Debt DTIL (Precision BioSciences Inc.)|Company Long-Term Debts GBIO (Generation Bio)|Boundless Bio Inc (BOLD) - Long-Term Debt|Exicure Corp - Company Long-Term Debts|IMNN (Imunon, Inc.) - Company Long-Term Indebtedness|phiopharma.com (PHIO) - Company Long-Term Debt|Company Long-Term Indebtedness MBIO|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Debts Bionano|Company Long-Term Liabilities APDN (Applied DNA Sciences)|Company Long-Term Liabilities bluebirdbio.com BLUE|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|OMIC: Company Long-Term Liabilities|RGLS: Company Long-Term Debt|SYRS: Company Long-Term Debts|Long-Term Debt telesisbio.com (TBIO)|Company Long-Term Liabilities TCON|UBX: Company Long-Term Loans and Borrowings